Show items per page
Elements: 223
Page 1 on 12
 TitleAuthors / EditorsDate
add to browser selection
Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy Girardin, François; Painter, Chris; Hearmon, Natalie; Eddowes, Lucy; ... Vernaz-Hegi, Nathalie 2021
add to browser selection
Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland Müllhaupt, Beat; Semela, David; Ruckstuhl, Lisa; Magenta, Lorenzo; ... Semmo, Nasser 2021
add to browser selection
Residual risk of liver disease after hepatitis C virus eradication Negro, Francesco 2021
add to browser selection
NAFLD and MAFLD as emerging causes of HCC: a populational study Myers, Shuna; Neyroud, Isabelle; Spahr, Laurent François Joséph; Gkouvatsos, Konstantinos; ... Goossens, Nicolas 2021
add to browser selection
Real-world outcomes in historically underserved patients with chronic hepatitis C infection treated with Glecaprevir/Pibrentasvir Aghemo, Alessio; Horsmans, Yves; Bourgeois, Stefan; Bondin, Mark; ... Lampertico, Pietro 2021
add to browser selection
The changing context of hepatitis D. Rizzetto, Mario; Hamid, Saeed; Negro, Francesco 2021
add to browser selection
Recommandations pour le suivi des patients atteints d’hépatite C guérie Bobzin, Carina; Bsiger, Christophe; Bruggmann, Philip; Cerny, Andreas; ... Thurnheer, Maria Christine 2021
add to browser selection
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective Fouad, Yasser; Lazarus, Jeffrey V; Negro, Francesco; Peck-Radosavljevic, Markus; ... Colombo, Massimo 2021
add to browser selection
Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis Correia De Sousa, Marta; Calo, Nicolas Virgile; Sobolewski, Cyril; Gjorgjieva, Monika; ... Foti, Michelangelo 2021
add to browser selection
HDV pathogenesis: unravelling ariadne's thread Tseligka, Eirini; Clément Leboube, Sophie; Negro, Francesco 2021
add to browser selection
Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis Sadeghimehr, Maryam; Bertisch, Barbara; Negro, Francesco; Butsashvili, Maia; ... Estill, Janne Anton Markus 2021
add to browser selection
Maladies infectieuses Nguyen, Aude; Posfay Barbe, Klara; Blanchard Rohner, Géraldine; Buvelot, Hélène; ... Csaki Huttner, Angela 2021
add to browser selection
Natural history of NASH and HCC. Negro, Francesco 2020
add to browser selection
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic hcv infection: a meta-analysis Lampertico, Pietro; Carrión, Jose A; Curry, Michael; Turnes, Juan; ... Wedemeyer, Heiner 2020
add to browser selection
SARS-CoV-2 and liver damage: a possible pathogenetic link Abenavoli, Ludovico; Gentile, Ivan; Maraolo, Alberto Enrico; Negro, Francesco 2020
add to browser selection
Securing sustainable funding for viral hepatitis elimination plans Hatzakis, Angelos; Lazarus, Jeffrey V; Cholongitas, Evangelos; Baptista-Leite, Ricardo; ... Manns, Michael P 2020
add to browser selection
All-Cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (SCCS) Roelens, Maroussia; Bertisch, Barbara; Moradpour, Darius; Cerny, Andreas; ... Keiser, Olivia 2020
add to browser selection
Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis? Negro, Francesco 2020
add to browser selection
Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies Alfaiate, Dulce; Clement, Sophie; Rocha Gomes, Diana Bianca; Goossens, Nicolas; Negro, Francesco 2020
add to browser selection
Reply to: "Cirrhotic controls in a pooled analysis of hepatitis D and hepatocellular carcinoma" Alfaiate, Dulce; Clement, Sophie; Goossens, Nicolas; Negro, Francesco 2020
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 ...11 | 12 |